Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 12 04:00PM ET
5.52
Dollar change
+0.10
Percentage change
1.85
%
Index- P/E- EPS (ttm)-3.10 Insider Own26.74% Shs Outstand89.08M Perf Week9.31%
Market Cap492.06M Forward P/E- EPS next Y-1.34 Insider Trans-0.51% Shs Float65.31M Perf Month22.94%
Income-218.86M PEG- EPS next Q-0.44 Inst Own76.23% Short Float6.33% Perf Quarter50.41%
Sales-1.27M P/S- EPS this Y60.55% Inst Trans73.14% Short Ratio4.61 Perf Half Y13.11%
Book/sh2.26 P/B2.44 EPS next Y23.25% ROA-68.70% Short Interest4.13M Perf Year213.64%
Cash/sh2.29 P/C2.41 EPS next 5Y30.31% ROE-83.24% 52W Range1.58 - 7.27 Perf YTD46.03%
Dividend Est.- P/FCF- EPS past 5Y-78.71% ROIC-108.48% 52W High-24.07% Beta-0.58
Dividend TTM- Quick Ratio12.05 Sales past 5Y127.75% Gross Margin805.35% 52W Low250.48% ATR (14)0.39
Dividend Ex-DateMar 28, 2018 Current Ratio12.05 EPS Y/Y TTM-197.69% Oper. Margin13470.91% RSI (14)59.16 Volatility4.97% 4.88%
Employees123 Debt/Eq0.01 Sales Y/Y TTM-100.32% Profit Margin17205.74% Recom1.43 Target Price10.80
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q76.07% Payout- Rel Volume1.16 Prev Close5.42
Sales Surprise- EPS Surprise11.58% Sales Q/Q-100.00% EarningsMay 08 BMO Avg Volume896.56K Price5.52
SMA206.60% SMA5017.52% SMA20034.91% Trades Volume1,036,432 Change1.85%
Date Action Analyst Rating Change Price Target Change
May-30-25Initiated TD Cowen Buy
Apr-07-25Upgrade Mizuho Neutral → Outperform $7
Nov-18-24Upgrade Robert W. Baird Neutral → Outperform $3 → $11
Oct-23-24Upgrade BofA Securities Neutral → Buy $4.20 → $10
Mar-18-24Downgrade Mizuho Buy → Neutral $32 → $4
Mar-11-24Downgrade Robert W. Baird Outperform → Neutral $37 → $4
Mar-11-24Downgrade Leerink Partners Outperform → Market Perform $27 → $4
Mar-08-24Downgrade Goldman Buy → Neutral
Mar-08-24Downgrade Evercore ISI Outperform → In-line
Jan-03-24Initiated Robert W. Baird Outperform $37
Jun-03-25 07:00AM
May-21-25 07:00AM
May-20-25 09:55AM
May-12-25 07:00AM
May-09-25 03:12AM
07:00AM Loading…
May-08-25 07:00AM
May-07-25 06:00PM
08:00AM
May-01-25 09:00AM
06:06AM
Apr-30-25 07:00AM
Apr-16-25 11:22AM
Apr-11-25 08:11AM
Apr-10-25 07:03AM
Apr-09-25 07:00AM
09:00AM Loading…
Apr-02-25 09:00AM
Mar-27-25 10:17AM
Mar-05-25 10:01AM
Mar-04-25 06:00AM
Mar-03-25 07:18AM
Feb-25-25 09:00AM
Feb-24-25 09:00AM
Feb-10-25 09:00AM
Jan-31-25 12:00PM
Jan-22-25 05:00AM
Jan-21-25 09:00AM
Jan-10-25 08:26AM
Jan-09-25 07:30PM
Jan-06-25 09:00AM
Dec-30-24 02:52PM
07:35AM Loading…
Dec-05-24 07:35AM
Dec-04-24 07:30AM
Nov-27-24 09:00AM
Nov-08-24 02:11AM
01:33AM
Nov-07-24 07:00AM
Nov-04-24 09:00AM
Oct-25-24 09:05PM
Oct-19-24 11:12AM
Oct-18-24 07:34AM
07:26AM
07:04AM
Oct-17-24 09:00AM
Oct-15-24 09:00AM
Oct-09-24 05:32PM
Sep-09-24 07:17PM
Sep-06-24 01:49AM
Aug-28-24 08:30AM
Aug-12-24 09:00AM
Aug-08-24 07:00AM
Aug-05-24 09:00AM
04:32AM
Aug-02-24 09:00AM
Jul-10-24 10:53AM
07:00AM
03:00AM
Jul-09-24 04:01PM
Jun-28-24 11:02AM
Jun-04-24 09:00AM
May-14-24 07:25AM
May-10-24 03:54PM
12:47PM
May-09-24 08:15AM
07:00AM
May-08-24 09:00AM
May-02-24 09:00AM
Apr-30-24 12:02PM
Apr-10-24 03:14PM
09:00AM
Apr-08-24 09:00AM
Apr-04-24 01:20PM
10:05AM
07:52AM
07:43AM
07:07AM
07:00AM
06:09AM
Apr-03-24 05:45AM
Apr-01-24 07:30PM
Mar-27-24 07:36AM
Mar-25-24 02:33PM
Mar-14-24 06:49PM
09:00AM
Mar-13-24 10:00AM
09:03AM
Mar-12-24 07:55AM
Mar-11-24 12:34PM
07:45AM
Mar-10-24 08:00AM
Mar-08-24 06:27PM
04:05PM
11:30AM
10:20AM
10:12AM
09:38AM
09:26AM
07:07AM
07:00AM
02:05AM
Feb-27-24 05:45AM
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FRATES JAMES MChief Financial OfficerMar 31 '25Sale3.4710,89637,806290,988Apr 02 05:22 PM
Bedrosian Camille LChief Medical OfficerMar 31 '25Sale3.4712,42543,082194,375Apr 02 05:14 PM
Mazzariello GinaChief Legal OfficerMar 31 '25Sale3.489,19231,954187,969Apr 02 05:12 PM
Cohen Joshua BCo-Chief Executive OfficerMar 31 '25Sale3.4721,49074,4823,355,280Apr 02 04:57 PM
Klee Justin B.Co-Chief Executive OfficerMar 31 '25Sale3.4621,49074,4543,355,276Apr 02 04:52 PM
Zeiher Bernhardt GDirectorMar 20 '25Buy3.7010,00037,00510,000Mar 24 04:15 PM
Klee Justin B.Co-Chief Executive OfficerMar 03 '25Sale3.154,59514,4833,196,648Mar 05 04:35 PM
Cohen Joshua BCo-Chief Executive OfficerMar 03 '25Sale3.174,59514,5493,196,652Mar 05 04:32 PM
Mazzariello GinaChief Legal OfficerMar 03 '25Sale3.121,6115,022133,310Mar 05 04:32 PM
Mazzariello GinaChief Legal OfficerFeb 24 '25Sale3.154,16913,145134,921Feb 26 04:35 PM
Klee Justin B.Co-Chief Executive OfficerFeb 05 '25Option Exercise1.5736,31057,0073,201,243Feb 06 08:17 PM
Mazzariello GinaChief Legal OfficerFeb 03 '25Sale3.493,67812,839139,090Feb 05 04:58 PM
Cohen Joshua BCo-Chief Executive OfficerFeb 03 '25Sale3.4711,85141,1083,201,247Feb 05 04:55 PM
Klee Justin B.Co-Chief Executive OfficerFeb 03 '25Sale3.4711,85541,1043,164,933Feb 05 04:54 PM
Klee Justin B.Co-Chief Executive OfficerJan 06 '25Sale4.047,47130,2023,176,788Jan 08 05:29 PM
Cohen Joshua BCo-Chief Executive OfficerJan 06 '25Sale4.057,47130,2323,213,098Jan 08 05:26 PM
Bedrosian Camille LChief Medical OfficerDec 02 '24Sale5.545,42130,007138,380Dec 03 05:21 PM
Klee Justin B.Co-Chief Executive OfficerNov 04 '24Option Exercise1.5763,69099,9933,184,259Nov 06 07:24 PM
Klee Justin B.Co-Chief Executive OfficerSep 30 '24Sale3.2018,58959,4293,120,569Oct 02 06:53 PM
Cohen Joshua BCo-Chief Executive OfficerSep 30 '24Sale3.2018,58959,4143,220,569Oct 02 06:53 PM
Bedrosian Camille LChief Medical OfficerSep 30 '24Sale3.2011,44236,559143,801Oct 02 06:50 PM
Mazzariello GinaChief Legal OfficerSep 30 '24Sale3.208,70927,840142,768Oct 02 06:48 PM
Cohen Joshua BCo-Chief Executive OfficerSep 23 '24Option Exercise1.571,8572,9153,239,158Sep 25 05:56 PM
Cohen Joshua BCo-Chief Executive OfficerSep 12 '24Option Exercise1.5734,44954,0853,237,301Sep 16 05:39 PM
FRATES JAMES MChief Financial OfficerSep 12 '24Buy2.5340,000101,368233,464Sep 16 05:30 PM
Firestone KarenDirectorSep 05 '24Buy2.1350,000106,59055,000Sep 09 04:05 PM
MILNE GEORGE M JRDirectorSep 03 '24Buy2.20100,000219,800858,571Sep 05 07:26 PM